(Q38211598)

31 August 2017

Casein kinase: the triple meaning of a misnomer (English)

1 reference

31 August 2017

Maria Ruzzene

2

0 references

Lorenzo A Pinna

object named as

Lorenzo A Pinna

series ordinal

3

0 references

author name string

Andrea Venerando

series ordinal

1

1 reference

PubMed ID

24825444

31 August 2017

language of work or name

English

0 references

publication date

1 June 2014

1 reference

31 August 2017

1 reference

31 August 2017

460

1 reference

31 August 2017

2

1 reference

31 August 2017

141-156

1 reference

Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia

31 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Synthetic fragments of beta-casein as model substrates for liver and mammary gland casein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Secreted kinase phosphorylates extracellular proteins that regulate biomineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

AtaA, a new member of the trimeric autotransporter adhesins from Acinetobacter sp. Tol 5 mediating high adhesiveness to various abiotic surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

21 January 2018

Secreted protein kinases

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Phosphorylation of caseins, present evidence for an amino acid triplet code posttranslationally recognized by specific kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Purification and tissue-specific expression of casein kinase from the lactating guinea-pig mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Purification of Golgi casein kinase from bovine milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Analysis of a sub-proteome which co-purifies with and is phosphorylated by the Golgi casein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Whole-Exome sequencing identifies FAM20A mutations as a cause of amelogenesis imperfecta and gingival hyperplasia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Novel FAM20A mutations in hypoplastic amelogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Crystal structure of the Golgi casein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Crystal structure of the catalytic subunit of protein kinase CK2 from Zea mays at 2.1 A resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Novel consensus sequence for the Golgi apparatus casein kinase, revealed using proline-rich protein-1 (PRP1)-derived peptide substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Unknown syndrome: microcephaly, hypoplastic nose, exophthalmos, gum hyperplasia, cleft palate, low set ears, and osteosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Osteosclerotic bone dysplasia in siblings with a Fam20C mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Mutations in FAM20C also identified in non-lethal osteosclerotic bone dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

FAM20C plays an essential role in the formation of murine teeth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Nephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

FAM20A mutations can cause enamel-renal syndrome (ERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The SCPP gene family and the complexity of hard tissues in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Isolation and sequencing of cDNA clones encoding alpha and beta subunits of Drosophila melanogaster casein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 2: an 'eminence grise' in cellular regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinases: pleiotropic mediators of cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2: a challenge to canons

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2: structure, regulation and role in cellular decisions of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase II in signal transduction and cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The Genes Encoding Human Protein Kinase CK2 and Their Functional Links

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

One-thousand-and-one substrates of protein kinase CK2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Joining the cell survival squad: an emerging role for protein kinase CK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Emergence of protein kinase CK2 as a key target in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 2 as a potentially important enzyme in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2, an important regulator of the inflammatory response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

ATP site-directed inhibitors of protein kinase CK2: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 inhibitors: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Kinase CK2 inhibition: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2: a new view of an old molecular complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Active form of the protein kinase CK2 α2β2 holoenzyme is a strong complex with symmetric architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 and its role in cellular proliferation, development and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CK2α is essential for embryonic morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Inhibition of casein kinase 2 modulates XBP1-GRP78 arm of unfolded protein responses in cultured glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A peptide-based target screen implicates the protein kinase CK2 in the global regulation of caspase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Threonine 393 of beta-catenin regulates interaction with Axin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The casein kinase 2-nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Spinal CK2 regulates nociceptive signaling in models of inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Pharmacokinetic characterization of CK2 inhibitor CX-4945.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Identification of the in vivo phosphorylation sites for acidic-directed kinases in murine mdr1b P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Multiple myeloma cell survival relies on high activity of protein kinase CK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells: biochemical evidence and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathwa

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 inhibition down modulates the NF-κB and STAT3 survival pathways, enhances the cellular proteotoxic stress and synergistically boosts the cytotoxic effect of bortezomib on multiple myeloma and mantle cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Purification of casein kinase I and isolation of cDNAs encoding multiple casein kinase I-like enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Autophosphorylation of carboxy-terminal residues inhibits the activity of protein kinase CK1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Structural features underlying the multisite phosphorylation of the A domain of the NF-AT4 transcription factor by protein kinase CK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Chemical dissection of the APC Repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Isoform specific phosphorylation of p53 by protein kinase CK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

pLogo: a probabilistic approach to visualizing sequence motifs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The casein kinase 1 family: participation in multiple cellular processes in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 1: Complexity in the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A phosphatidylinositol 4,5-bisphosphate-sensitive casein kinase I alpha associates with synaptic vesicles and phosphorylates a subset of vesicle proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Crystal structure of a conformation-selective casein kinase-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK1α regulates erythrocyte survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Unwinding the Wnt action of casein kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Pyrvinium pamoate does not activate protein kinase CK1, but promotes Akt/PKB down-regulation and GSK3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Wnt/β-catenin signalling: from plasma membrane to nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 1-dependent phosphorylation of familial advanced sleep phase syndrome-associated residues controls PERIOD 2 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

The flaviviral methyltransferase is a substrate of Casein Kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Amyloid beta-protein stimulates casein kinase I and casein kinase II activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Mechanisms of specificity in protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Protein kinase CK2 accumulation in "oncophilic" cells: causes and effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Isolation of phosphorylated peptides and proteins on ion exchange papers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Substrate-specificity determinants for a membrane-bound casein kinase of lactating mammary gland.. A study with synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

Amino-Acid Sequence and the Occurrence of Phosphorus in Human Fibrinopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20140178

21 January 2018

Identifiers

DOI

10.1042/BJ20140178

1 reference

31 August 2017

1 reference

PubMed ID

24825444